The Flutracking team ( have just announced a new postdoctoral position, which will translate learning from Flutracking into monitoring medical cannabis patients.

This position will work on cutting edge digital surveillance methods to optimise survey response among patients in a medical cannabis trial. The position will be embedded within the team to help transfer learnings from Flutracking (the largest public health participatory surveillance system in the world) to digital pharmaco-vigilance of medical cannabis patients. The trial is funded by NSW Health and is governed by the University of Newcastle led ACRE (Australian Centre for Cannabinoid Clinical and Research Excellence), research program into medical cannabis.  The trial is an observational multi-centre ‘real world’ clinical study of 600 patients across New South Wales clinical sites. The study will enable a trial of cannabinoid product by people with advanced cancer who are ineligible for current trials and who are suffering from symptoms that are not responding to current therapies.

The focus of the position will be on optimising participant response rates and data quality through cutting edge user experience innovations including rigorous user testing and split testing of questionnaires and technology. User empathy and creative split testing of user interfaces and questionnaire structure will be a key determinant of success in the position. Additionally, this position will have a lead role in data architecture including combining data from multiple data sources and producing reports for the wider research team. The position will have the opportunity to develop their own research projects.

For more information about this position, please contact Craig Dalton (

About Newcastle (No. 9 on Lonely Planet’s Top 10 Cities in the World to Visit in 2011!)